Inventor

SLASSI ABDELMALIK

CA58 patents

⚠️ This page may combine multiple inventors who share the name “SLASSI ABDELMALIK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SLASSI ABDELMALIK

ASTRAZENECA AB

Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists

Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators

Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists

Metabotropic glutamate receptor oxadiazole ligands and their use as potentiators 841

Pharmaceutically active compounds containing tetrazolyl and triazolyl rings

Substituted isoindolones and their use as metabotropic glutamate receptor potentiators

Compounds for the treatment of neurological, psychiatric or pain disorders

Compounds

Metabotropic glutamate-receptor-potentiating isoindolones

mGluR5 modulators

Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators—842

Isoindolone compounds and their use as metabotropic glutamate receptor potentiators

MGluR5 modulators I

Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators 842

Piperazines and piperidines as Mglur5 potentiators

Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators

NPS ALLELIX CORP

Bicyclic piperidine and piperazine compounds having 5-HT6 receptor affinity

Azaindoles having serotonin receptor affinity

Azaindoles having serotonin receptor affinity

Azaindoles having serotonin receptor affinity

Use of N-alkylamino-heterocylic compounds for the treatment of migraine

Azaindoles having serotonin receptor affinity

Compounds having 5-HT6 receptor antagonist activity

N-alkylamino-indoles for the treatment of migraine

3-bicycloindole compounds

5-Bicycloindole compounds

MINDSET PHARMA INC

Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disorders

Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disorders

Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disorders

Scalable synthetic route for psilocin and psilocybin

3-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the treatment of CNS disorders

Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disorders

3-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the treatment of CNS disorders

Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disorders

ALLELIX BIOPHARMA

Piperidine-indole compounds having 5-HT6 affinity

Pyrrolidine-indole compounds having 5-HT6 affinity

5-cyclo indole compounds

5-alkenyl and 5-alkynyl indole compounds

Anti-viral guanidino-substituted compounds

TRILLIUM THERAPEUTICS INC

Fluorinated imidazo[4,5-C]quinoline derivatives as inhibitors of bromodomain containing proteins

Fluorinated amide derivatives and their uses as therapeutic agents

Heterocycle derivatives and their use for the treatment of CNS disorders

Fluorinated imidazo[4,5-C]quinoline derivatives as inhibitors of bromodomain containing proteins

NPS PHARMA INC

Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists

Compounds

NPS ALLELIX BIOPHARMACEUTICALS

Heterocyclic compounds for the treatment of migraine

FLUORINOV PHARMA INC

Fluorinated epoxyketone-based compounds and uses thereof as proteasome inhibitors

(unassigned)

5-alkoxy tryptamine derivatives

EDWARDS LOUISE

Azaindoles having serotonin receptor affinity

ALLELIX NEUROSCIENCE INC

Unsaturated amino acid derivatives